2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 114 filers reported holding 2SEVENTY BIO INC in Q4 2023. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $817 | -8.4% | 212,613 | +27.5% | 0.00% | – |
| Q1 2024 | $892 | +150.6% | 166,722 | +99.5% | 0.00% | – |
| Q4 2023 | $356 | +111.9% | 83,552 | +93.8% | 0.00% | – |
| Q3 2023 | $168 | -86.5% | 43,118 | -64.9% | 0.00% | -100.0% |
| Q2 2023 | $1,244 | -69.1% | 122,778 | -68.8% | 0.00% | -50.0% |
| Q1 2023 | $4,021 | +456.9% | 394,126 | +411.8% | 0.00% | – |
| Q4 2022 | $722 | -99.9% | 77,002 | -7.6% | 0.00% | -100.0% |
| Q3 2022 | $1,213,000 | +2105.5% | 83,334 | +1914.8% | 0.00% | – |
| Q2 2022 | $55,000 | -38.9% | 4,136 | -21.4% | 0.00% | – |
| Q1 2022 | $90,000 | – | 5,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |